Ciclosporin ocular implant (Lux Biosciences)

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameCiclosporin ocular implant (Lux Biosciences)
Drug Alias NameLUMITECTLX-201LX201
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCalcineurin inhibitorsP-glycoprotein 1 inhibitorsMitocliondrial permeability transition pore inhibitors
TargetsCalcineurinMitocliondrial permeability transition poreP-glycoprotein 1
Therapy Area/IndicationsRejection of organ transplantationKeratoplasty rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of HealthLux Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthLux Biosciences Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationKeratoplasty rejection

Other Information

ATC CodeN/A
Related LinksN/A